Combination products are being developed and manufactured at a record rate. The process of getting these products approved often includes steps that typically fall only to pharmaceutical regulatory experts or only to medical device regulatory experts. This can create significant hurdles when trying to understand and implement continually evolving industry standards and mandates required by Global Health Authorities; plus, there are added nuances applied to regulations for combination products. As a result, more and more customers are coming to Reed Tech with questions.
In this free, educational webinar, Reed Tech subject-matter experts, Gary Saner, Sr. Manager, Information Solutions, David Wilson, Pharma Team Lead and Gabriel Adams, Medical Device Account Executive, reviewed these requirements, presented some real-life scenarios brought forth by our customers and answered questions in a live Q+A session. Watch now!
• Defining a combination product
• Pharmaceutical registration requirements
• Medical Device registration requirements
• Special combination requirements
• Real life examples
• Q + A
In 2019, Reed Tech authored a blog post offering critical background information on combination medical device and drug products. This piece examines required actions for products including both a medical device constituent and a drug constituent. Read this blog to prepare for our upcoming combination products webinar that will take a closer look at this topic and provide answers to your questions.
Reed Tech is the provider of best-in-class information-based solutions and services to meet the needs of the life sciences industry, government agencies, and the intellectual property market. Our customers are located throughout the world and include a wide range of medical device manufacturers and pharmaceutical companies, the U.S. government, numerous Patent Authorities, and IP-driven companies and law firms. The corporate mission is to advance humanity by delivering better outcomes to the innovation community. Reed Tech is a LexisNexis company.
For more information: Pharma@ReedTech.com, +1-215-557-3010